These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18014217)

  • 1. Use of Convalescent Measles Serum to Control Measles in a Preparatory School.
    Gallagher JR
    Am J Public Health Nations Health; 1935 May; 25(5):595-8. PubMed ID: 18014217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylaxis and treatment of measles with convalescent serum intradermally].
    ALVAREZ RIANO AM
    Pediatr Am; 1947 Jan; 5(1):40-6. PubMed ID: 20239918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to measles prophylaxis by intradermal injection of convalescent serum].
    VELEZ HA
    Pediatr Am; 1947 Feb; 5(2):65-7. PubMed ID: 20239922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of measles by convalescent serum eye drops].
    JOVANOVIC D
    Med Glas; 1958 Mar; 12(3):118-22. PubMed ID: 13565141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempted prevention of measles in child centers by means of instillation of convalescent serum in the eyes (preliminary communication)].
    JAROSZYNSKA-WEINBERGER B
    Arch Fr Pediatr; 1960; 17():509-15. PubMed ID: 14406838
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating D-dimer and thrombomodulin levels in acute febrile phase of measles.
    Ohnishi K; Kato Y
    J Infect; 2002 Oct; 45(3):180-3. PubMed ID: 12387775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of serum vascular cell adhesion molecule-1 in measles.
    Ohnishi K; Kato Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):852-4. PubMed ID: 12757238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles reimmunization in children immunized before 1 year of age.
    Lampe RM; Weir MR; Scott RM; Weeks JL
    Am J Dis Child; 1985 Jan; 139(1):33-5. PubMed ID: 3969979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum agglutination by convalescent sera of erythrocytes during the course of measles].
    LOZOVSKAIA LS
    Vopr Virusol; 1958; 3(4):242-3. PubMed ID: 13593294
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralisation of canine-distemper virus by serum of patients convalescent from measles.
    CARLSTROM G
    Lancet; 1957 Aug; 273(6990):344. PubMed ID: 13464060
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-exposure to wild-type virus stabilizes measles-specific antibody levels in late convalescent patients.
    Kremer JR; Bouche FB; Schneider F; Muller CP
    J Clin Virol; 2006 Jan; 35(1):95-8. PubMed ID: 16137922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the neutralization capacity of different types of human measles virus vaccine and the epidemic strains].
    Feng Y; Lu YY; Yan JY; Jiang XH; Shi W; Xu CP; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1123-6. PubMed ID: 18396671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles virus-specific immunoglobulin G isotype immune response in early and late infections.
    Isa MB; Martínez L; Giordano M; Zapata M; Passeggi C; De Wolff MC; Nates S
    J Clin Microbiol; 2001 Jan; 39(1):170-4. PubMed ID: 11136766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons.
    Damien B; Huiss S; Schneider F; Muller CP
    J Med Virol; 1998 Sep; 56(1):85-90. PubMed ID: 9700638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to structural proteins of measles virus in patients with natural measles and subacute sclerosing panencephalitis.
    Sato TA; Hayami M; Yamanouchi K
    Jpn J Med Sci Biol; 1981 Dec; 34(6):365-73. PubMed ID: 7334708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187.
    Zingher A; Mortimer P
    Rev Med Virol; 2005; 15(6):407-18; discussion 418-21. PubMed ID: 16211552
    [No Abstract]   [Full Text] [Related]  

  • 17. Bronchoalveolar lavage cell analysis in measles viral pneumonia.
    Myou S; Fujimura M; Yasui M; Ueno T; Matsuda T
    Eur Respir J; 1993 Nov; 6(10):1437-42. PubMed ID: 8112435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of acute measles infections by indirect and mu-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay.
    Tuokko H
    J Med Virol; 1995 Mar; 45(3):306-11. PubMed ID: 7775952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.
    El Mubarak HS; Ibrahim SA; Vos HW; Mukhtar MM; Mustafa OA; Wild TF; Osterhaus AD; de Swart RL
    J Med Virol; 2004 Feb; 72(2):290-8. PubMed ID: 14695672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE).
    Shainkin-Kestenbaum R; Zimlichman S; Winikoff Y; Pras M; Chaimovitz C; Sarov I
    Clin Exp Immunol; 1982 Dec; 50(3):503-6. PubMed ID: 7165997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.